Reynders McVeigh Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $336K | Sell |
11,972
-1,131
| -9% | -$30.1K | 0.02% | 153 |
|
|
2025
Q4 | $326K | Sell |
13,103
-2,770
| -17% | -$69.9K | 0.02% | 154 |
|
|
2025
Q3 | $404K | Sell |
15,873
-1,935
| -11% | -$47.8K | 0.02% | 139 |
|
|
2025
Q2 | $432K | Sell |
17,808
-1,606
| -8% | -$37.5K | 0.02% | 141 |
|
|
2025
Q1 | $492K | Sell |
19,414
-1,932
| -9% | -$50.6K | 0.03% | 137 |
|
|
2024
Q4 | $566K | Sell |
21,346
-600
| -3% | -$16.3K | 0.03% | 134 |
|
|
2024
Q3 | $635K | Buy |
21,946
+2,100
| +11% | +$61.3K | 0.03% | 132 |
|
|
2024
Q2 | $555K | Sell |
19,846
-1,535
| -7% | -$42.3K | 0.03% | 135 |
|
|
2024
Q1 | $594K | Sell |
21,381
-370
| -2% | -$10.3K | 0.03% | 130 |
|
|
2023
Q4 | $626K | Sell |
21,751
-7,209
| -25% | -$218K | 0.04% | 123 |
|
|
2023
Q3 | $961K | Sell |
28,960
-4,817
| -14% | -$170K | 0.07% | 92 |
|
|
2023
Q2 | $1.24M | Sell |
33,777
-1,726
| -5% | -$67.2K | 0.08% | 87 |
|
|
2023
Q1 | $1.45M | Buy |
35,503
+3,117
| +10% | +$135K | 0.1% | 80 |
|
|
2022
Q4 | $1.66M | Sell |
32,386
-2,946
| -8% | -$141K | 0.12% | 76 |
|
|
2022
Q3 | $1.55M | Buy |
35,332
+1,859
| +6% | +$90.3K | 0.12% | 79 |
|
|
2022
Q2 | $1.75M | Sell |
33,473
-3,653
| -10% | -$186K | 0.13% | 74 |
|
|
2022
Q1 | $1.92M | Sell |
37,126
-1,448
| -4% | -$75.1K | 0.12% | 78 |
|
|
2021
Q4 | $2.28M | Sell |
38,574
-500
| -1% | -$24.8K | 0.13% | 77 |
|
|
2021
Q3 | $1.68M | Buy |
39,074
+357
| +0.9% | +$15.8K | 0.1% | 88 |
|
|
2021
Q2 | $1.52M | Sell |
38,717
-20,843
| -35% | -$811K | 0.09% | 92 |
|
|
2021
Q1 | $2.16M | Buy |
59,560
+7,288
| +14% | +$259K | 0.14% | 78 |
|
|
2020
Q4 | $1.92M | Sell |
52,272
-9,776
| -16% | -$359K | 0.13% | 71 |
|
|
2020
Q3 | $2.16M | Sell |
62,048
-4,058
| -6% | -$142K | 0.17% | 64 |
|
|
2020
Q2 | $2.05M | Sell |
66,106
-1,668
| -2% | -$56.7K | 0.18% | 64 |
|
|
2020
Q1 | $2.1M | Buy |
67,774
+717
| +1% | +$24.4K | 0.24% | 62 |
|
|
2019
Q4 | $2.49M | Sell |
67,057
-1,259
| -2% | -$44.8K | 0.24% | 63 |
|
|
2019
Q3 | $2.33M | Buy |
68,316
+8,127
| +14% | +$296K | 0.25% | 63 |
|
|
2019
Q2 | $2.47M | Sell |
60,189
-1,388
| -2% | -$55.1K | 0.27% | 62 |
|
|
2019
Q1 | $2.48M | Buy |
61,577
+3,780
| +7% | +$151K | 0.27% | 64 |
|
|
2018
Q4 | $2.39M | Sell |
57,797
-1,777
| -3% | -$73.8K | 0.32% | 60 |
|
|
2018
Q3 | $2.49M | Sell |
59,574
-3,317
| -5% | -$128K | 0.29% | 61 |
|
|
2018
Q2 | $2.17M | Buy |
62,891
+9,553
| +18% | +$326K | 0.28% | 64 |
|
|
2018
Q1 | $1.8M | Buy |
53,338
+3,103
| +6% | +$107K | 0.23% | 68 |
|
|
2017
Q4 | $1.73M | Sell |
50,235
-646
| -1% | -$22K | 0.23% | 72 |
|
|
2017
Q3 | $1.72M | Sell |
50,881
-1,960
| -4% | -$63K | 0.22% | 72 |
|
|
2017
Q2 | $1.68M | Sell |
52,841
-325
| -0.6% | -$10.2K | 0.23% | 73 |
|
|
2017
Q1 | $1.73M | Sell |
53,166
-584
| -1% | -$18.4K | 0.24% | 78 |
|
|
2016
Q4 | $1.66M | Sell |
53,750
-2,896
| -5% | -$88.4K | 0.24% | 77 |
|
|
2016
Q3 | $1.82M | Buy |
56,646
+392
| +0.7% | +$13.1K | 0.27% | 67 |
|
|
2016
Q2 | $1.88M | Buy |
56,254
+5,212
| +10% | +$166K | 0.27% | 71 |
|
|
2016
Q1 | $1.44M | Buy |
51,042
+2,012
| +4% | +$57.5K | 0.21% | 82 |
|
|
2015
Q4 | $1.5M | Sell |
49,030
-3,837
| -7% | -$121K | 0.25% | 67 |
|
|
2015
Q3 | $1.57M | Sell |
52,867
-5,197
| -9% | -$167K | 0.27% | 62 |
|
|
2015
Q2 | $1.85M | Buy |
58,064
+350
| +0.6% | +$11.4K | 0.3% | 55 |
|
|
2015
Q1 | $1.91M | Buy |
57,714
+4,301
| +8% | +$137K | 0.33% | 49 |
|
|
2014
Q4 | $1.58M | Buy |
53,413
+787
| +1% | +$22.6K | 0.28% | 59 |
|
|
2014
Q3 | $1.48M | Sell |
52,626
-30
| -0.1% | -$842 | 0.28% | 61 |
|
|
2014
Q2 | $1.48M | Buy |
52,656
+6,846
| +15% | +$195K | 0.34% | 57 |
|
|
2014
Q1 | $1.4M | Buy |
45,810
+1,950
| +4% | +$58.1K | 0.33% | 60 |
|
|
2013
Q4 | $1.27M | Hold |
43,860
| – | – | 0.32% | 62 |
|
|
2013
Q3 | $1.2M | Sell |
43,860
-80
| -0.2% | -$2.18K | 0.33% | 61 |
|
|
2013
Q2 | $1.17M | Buy |
+43,940
| New | +$1.21M | 0.35% | 63 |
|
Other funds holding PFE
Reynders McVeigh Capital Management's PFE Position: Q1 2026 in Review
Reynders McVeigh Capital Management reduced its Pfizer (PFE) stake by 8.6% in Q1 2026, selling an estimated $30.1K and leaving 11,972 shares worth $336K. The position accounts for 0.02% of the portfolio, ranked #153.
Reynders McVeigh Capital Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.49M in Q4 2019. 2,955 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Reynders McVeigh Capital Management held 11,972 shares of Pfizer worth $336K as of Q1 2026.
- Reynders McVeigh Capital Management sold 1,131 Pfizer shares in Q1 2026, an estimated $30.1K.
- Pfizer made up 0.02% of Reynders McVeigh Capital Management's portfolio in Q1 2026, its #153 holding.
- Reynders McVeigh Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Reynders McVeigh Capital Management's Pfizer position peaked at $2.49M in Q4 2019.
- 2,955 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Reynders McVeigh Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.